This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2hjl

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2hjl.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2hjl.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2hjl| PDB=2hjl | SCENE= }}
{{STRUCTURE_2hjl| PDB=2hjl | SCENE= }}
-
'''Crystal Structure of HLA-B5703 and HIV-1 peptide'''
+
===Crystal Structure of HLA-B5703 and HIV-1 peptide===
-
==Overview==
+
<!--
-
HLA-B*57 is associated with slower disease progression to AIDS, and CD8+ T cell responses to B*57-restricted epitopes are thought to contribute to this protective effect. In this study, we evaluate the B*57-restricted p24 KAFSPEVIPMF (KF11) immune response which is immunodominant during chronic infection. Previously, we observed that the KF11 clade variants KGFNPEVIPMF [A2G,S4N] and KAFNPEIIMPF [S4N,V7I], sharing a position 4 mutation, are differentially recognized by KF11-specific T cells. By combining structural and cellular studies, we now demonstrate that the KF11 and [A2G,S4N] epitopes induce distinct functional responses in [A2G,S4N] and KF11-specific T cells, respectively, despite minimal structural differences between the individual B*57-peptide complexes. Recently, we also elucidated the highly distinct structure of KF11 in complex with B*5703, and have now characterized the CD8+ T cell repertoire recognizing this epitope. We now report striking features of TCR conservation both in terms of TCR Valpha and Vbeta chain usage, and throughout the hypervariable region. Collectively, our findings highlight unusual features of the B*5701/B*5703-KF11-specific immune responses which could influence disease progression and that might be important to consider when designing future vaccine regimens.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16951352}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16951352 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16951352}}
==About this Structure==
==About this Structure==
Line 31: Line 35:
[[Category: Hiv]]
[[Category: Hiv]]
[[Category: Hla]]
[[Category: Hla]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 06:22:09 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 14:01:05 2008''

Revision as of 11:01, 28 July 2008

Image:2hjl.png

Template:STRUCTURE 2hjl

Crystal Structure of HLA-B5703 and HIV-1 peptide

Template:ABSTRACT PUBMED 16951352

About this Structure

2HJL is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Strong TCR conservation and altered T cell cross-reactivity characterize a B*57-restricted immune response in HIV-1 infection., Gillespie GM, Stewart-Jones G, Rengasamy J, Beattie T, Bwayo JJ, Plummer FA, Kaul R, McMichael AJ, Easterbrook P, Dong T, Jones EY, Rowland-Jones SL, J Immunol. 2006 Sep 15;177(6):3893-902. PMID:16951352

Page seeded by OCA on Mon Jul 28 14:01:05 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2hjl"
Personal tools